Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Quantitative analysis of ERR gamma conditional knock-out (cKO) acinar cell transcriptome

ABSTRACT: The goal of this study is to compare NGS-derived pancreatic acinar cell transcriptome profiling (RNA-seq) to analyze the alteration of transcriptional program depending on ERR gamma expression.

ORGANISM(S): Mus musculus

PROVIDER: GSE181529 | GEO | 2021/08/08

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Quantitative analysis of ERR gamma conditional knock-out (cKO) acinar cell transcriptome

Project description:Quantitative analysis of ERR gamma conditional knock-out (cKO) acinar cell transcriptome

| PRJNA752364 | ENA

Quantitative Analysis of ERR gamma-driven pancreatic acinar cell transcriptome

Project description:The goal of this study is to compare NGS-derived pancreatic acinar cell-based transcriptome profiling (RNA-seq) to evaluate ERR gamma-driven transcriptional program

2020-11-19 | GSE161757 | GEO

Quantitative Analysis of ERR gamma-driven pancreatic acinar cell transcriptome

Project description:Quantitative Analysis of ERR gamma-driven pancreatic acinar cell transcriptome

| PRJNA679301 | ENA

Rhizobium sp. ERR 922 isolate:ERR 922

Project description:Rhizobium sp. ERR 922 isolate:ERR 922 Genome sequencing and assembly

| PRJNA536632 | ENA

Rhizobium sp. ERR 942 isolate:ERR 942

Project description:Rhizobium sp. ERR 942 isolate:ERR 942 Genome sequencing and assembly

| PRJNA536631 | ENA

Novel pan-ERR agonists ameliorate heart failure through enhancing cardiac fatty acid metabolism and mitochondrial function

Project description:Cardiac metabolic dysfunction is a hallmark of heart failure. Estrogen related receptors ERRalpha and ERRgamma are essential regulators of cardiac metabolism. Therefore, activation of ERR could be a potential theraputic intervention for heart failure. However, in vivo studies demonstrating the potential utility of ERR agonists for heart failure treatment are lacking, as compounds with pharmackinetics appropriate for in vivo use have not been available. Using a structure-based design approach, we designed and synthesized two structurally distinct pan-ERR agonists, SLU-PP-332 (332) and SLU-PP-915 (915), which significantly improved ejection fraction, ameliorated fibrosis and increased survival associated with pressure overload-induced heart failure without affecting cardiac hypertrophy. Mechanistically, a broad spectrum of metabolic genes was transcriptionally activated by ERR agonists, particulary genes involved in fatty acid metabolism and mitochondrial function. Using both in vitro and in vivo genetic dependency experiments, we show that ERRgamma is the main mediatorof ERR agonism-induced transcriptional regulation and cardioprotection and definitively demonstrated target specificity. Additionally, ERR agonism also led to downregulation of cell cycle and development pathways, which was partially mediated by E2F1 in cardiomyocyte. In summary, ERR agonists maintain oxidative metabolism, which confers cardiac protection against pressure overload-induced heart failure in vivo. Our results provide direct pharmacological evidence supporting the further in vivo development of ERR agonists as novel heart failure theraputics.

2023-11-21 | GSE239912 | GEO

Novel pan-ERR agonists ameliorate heart failure through enhancing cardiac fatty acid metabolism and mitochondrial function

2024-01-01 | GSE241075 | GEO

Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells Decreases Pancreatitis-Induced Autophagy.

Project description: Not available

| S-EPMC5985122 | biostudies-literature

Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERR⍺ deficiency

Project description:Functional oncogenic links between ErbB2 and ERR⍺ in HER2+ breast cancer patients support a therapeutic benefit of co-targeted therapies. However, ErbB2 and ERR⍺ also play key roles in heart physiology, and this approach could pose a potential liability to cardiovascular health. Using integrated phosphoproteomic, transcriptomic and metabolic profiling, we uncovered molecular mechanisms associated with the adverse remodeling of cardiac functions in mice with combined attenuation of ErbB2 and ERR⍺ activity. Genetic disruption of both effectors results in profound effects on cardiomyocyte architecture, inflammatory response and metabolism, the latter leading to a decrease in fatty acyl-carnitine species further increasing the reliance on glucose as a metabolic fuel, a hallmark of failing hearts. Furthermore, integrated omics signatures of ERR⍺ loss-of-function and doxorubicin treatment exhibit reciprocal features of chemotherapeutic cardiotoxicity. These findings thus reveal potential cardiovascular risks in discrete combination therapies in the treatment of breast and other cancers.

2022-09-22 | PXD032766 | Pride

Ift172 conditional knock-out mice exhibit rapid retinal degeneration and protein trafficking defects.

Project description: Not available

| S-EPMC5961092 | biostudies-literature